International Edition

Tuesday, 20 October 2026

Private Trade News

Global markets, trading & world business — for professional traders

Trading

Ascletis Reports Positive Preclinical Data For Once-Weekly Oral Obesity Drug Pipeline

Cross-asset desk, Private Trade News (2026-10-20): (RTTNews) - Ascletis Pharma Inc. (1672.HK) announced positive preclinical data for its once-weekly oral peptide pipeline targeting obesity and other metabolic… Primary source: original at Nasdaq Market Structure (nasdaq.com).

· Nasdaq Market Structure

Ascletis Reports Positive Preclinical Data For Once-Weekly Oral Obesity Drug Pipeline

(RTTNews) - Ascletis Pharma Inc. (1672.HK) announced positive preclinical data for its once-weekly oral peptide pipeline targeting obesity and other metabolic diseases, highlighting extended half-lives and oral bioavailability.

Read at source